Skip to content

Effects of Triclosan-coated Sutures in Cardiac Surgery

Triclosan-coated Sutures in Cardiac Surgery:Effects on Leg Wound Infections and Costs

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01212315
Enrollment
392
Registered
2010-09-30
Start date
2009-03-31
Completion date
2012-06-30
Last updated
2012-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Wound Infection

Keywords

Wound infection, SSI, Suture

Brief summary

The purpose of this study is to assess if triclosan-coated sutures reduces wound infections after saphenous vein harvesting in CABG patients. Secondary objectives are the effect triclosan-coated sutures on sternal wound infections and a cost analysis.

Detailed description

The role of the suture material for the development of postoperative wound infection has been debated for many years. It has been reported that fewer bacteria adhere to monofilament polypropylene than braided polyester sutures in vitro but the results are opposed by a non-randomized clinical study where the use of monofilament sutures was identified as an independent risk factor for leg wound infections after CABG.

Interventions

DEVICETriclosan coated sutures

Subcutaneous and cutaneous sutures coated with triclosan (Vicryl Plus / Monocryl Plus) are used to close the incisions after vein harvesting and sternotomy. All wounds are inspected before discharge from hospital and the patients are instructed to contact the study coordinator if any suspected infection occurs. In addition, all patients are controlled after thirty days by a nurse and contacted by telephone sixty days after surgery to assess postoperative infections by a predefined questionnaire. Infection symptoms are graded according to the Asepsis score and the CDC classification. Patient records including bacterial cultures and antibiotic treatment are collected for all patients with suspected infections.

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective CABG at Sahlgrenska University Hospital with intended use of saphenous vein graft are included.

Exclusion criteria

* Patients with on-going sepsis or septicaemia, bacterial infections or known allergy to triclosan are excluded.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of subjects with leg wound infection.Within 60 days after heartsurgeryPrimary endpoint is postoperative leg wound infection within 60 days after surgery according to the definition of Center for Disease Control.

Secondary

MeasureTime frame
Culture-proven and antibiotic-treated wound infection after heart surgeryWithin 60 days after heart surgery

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026